Plain-English translation of NCT06954636 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers have noticed that people with glioblastoma (a serious type of brain tumor) often experience changes in their sense of smell, and these changes seem connected to survival and quality of life. This study will carefully track how smell function changes over time in newly-diagnosed glioblastoma patients, compared to a group of people without tumors, to see if smell changes are a reliable sign of how someone will respond to treatment and progress with their illness.
While earlier research suggested that olfactory impairment (loss of smell) in glioblastoma patients is associated with poorer outcomes, those earlier studies had limitations and didn't carefully follow smell changes over the long term or account for other important factors that affect survival. This trial aims to find out whether smell function is a true independent predictor of outcome—information that could help doctors better understand and personalize treatment for glioblastoma patients.
You likely qualify if…
You likely don't qualify if…
You will visit the study center multiple times from the time of your diagnosis through your treatment. At each visit, you'll complete smell tests using special scent sticks (identifying odors and detecting their strength), answer questions about your quality of life and thinking/memory abilities, and have brain imaging scans reviewed by specialists. You'll also provide blood samples for research into how your tumor and body respond at the cellular level. The study will follow you over time to see how your smell function changes and how this relates to your overall health and recovery.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Germany